back to Meetings page
- IMMPACT-XXI Slide Presentations
- 1. What do we mean by opioid sparing and what are its potential individual and societal benefits?
- Eric Strain, MD
- 2. Opioid-sparing clinical trial objectives and outcomes: Acute pain
- Tong Joo Gan, MD
- 3. Opioid-sparing clinical trial objectives and outcomes: Chronic pain
- Nathaniel Katz, MD
- 4. A regulatory perspective on opioid sparing clinical trial objectives and outcomes: Drugs
- Sharon Hertz, MD
- 5. A regulatory perspective on opioid sparing clinical trial objectives and outcomes: Devices
- Carlos Peña, PhD
- 6. Scoping review of methodologic characteristics of acute and chronic pain clinical trials of opioid sparing
- Shannon Smith, PhD
- 7. Assessing opioid use and opioid outcomes (e.g., dosage, time to event, duration of use)
- Brett Stacey, MD
- 8. Sparing of opioid-related patient-reported side effects and symptoms: Assessment and analysis
- Srinivasa Raja, MD
- 9. Sparing of opioid-related respiratory depression: Assessment and analysis
- Denham Ward, MD, PhD
- 10. Opioid sparing outcomes: What patient improvements and group differences would be clinically meaningful?
- John Markman, MD
- 11. Acute pain opioid sparing trials: Research designs, methods, and study execution
- Ian Gilron, MD
- 12. Chronic pain opioid sparing trials: Research designs, methods, and study execution
- Michael Rowbotham, MD